Graft vs Host Disease  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00195273: Study Evaluating Sirolimus in Kidney Transplant Recipients

Completed
3
61
Europe
sirolimus, cyclosporine, mycophenolate mofetil, corticosteroids, daclizumab
Wyeth is now a wholly owned subsidiary of Pfizer
Graft vs Host Disease, Kidney Transplantation
07/08
07/08
NCT00298324 / 2005-006178-86: Myfortic - Treatment for Extensive cGvHD

Terminated
3
34
Europe, RoW
Myfortic, Prednisone and Cyclosporine
European Society for Blood and Marrow Transplantation, Novartis
Graft vs Host Disease
11/09
11/10

Download Options